{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:34:05Z","timestamp":1774614845932,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T00:00:00Z","timestamp":1481068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.bjid.2017.03.019","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T17:30:41Z","timestamp":1496079041000},"page":"441-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors"],"prefix":"10.1016","volume":"21","author":[{"given":"Marlone","family":"Cunha-Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio R.T.","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo F.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tirzah M.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Sev\u00e1-Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia L.S.","family":"Lorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jazon R.S.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2017.03.019_bib0155","series-title":"Hepatitis B. Fact sheet number 204","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.bjid.2017.03.019_bib0160","series-title":"Estudo de preval\u00eancia de base populacional das infec\u00e7\u00f5es pelos v\u00edrus das hepatites A, B e C nas capitais do Brasil","author":"Minist\u00e9rio da Sa\u00fade","year":"2010"},{"key":"10.1016\/j.bjid.2017.03.019_bib0165","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jhep.2015.06.026","article-title":"Optimal management of hepatitis B virus infection \u2013 EASL Special Conference","volume":"63","author":"Lampertico","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2017.03.019_bib0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00430-014-0369-7","article-title":"Natural history of chronic hepatitis B virus infection","volume":"204","author":"Busch","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0185","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4254\/wjh.v7.i8.1097","article-title":"Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease","volume":"7","author":"Russo","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0190","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.3748\/wjg.v20.i37.13293","article-title":"Update on hepatitis B virus infection","volume":"20","author":"You","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2017.03.019_bib0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12072-010-9178-2","article-title":"Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units","volume":"4","author":"Galizzi","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.bjid.2017.03.019_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/hepatmon.7604","article-title":"Serolological profile among HBsAg-positive infections in Southeast China: a community-based study","volume":"13","author":"Chen","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1016\/j.bjid.2017.03.019_bib0210","doi-asserted-by":"crossref","first-page":"14559","DOI":"10.3748\/wjg.v20.i40.14559","article-title":"Hepatitis B virus and hepatitis C virus dual infection","volume":"20","author":"Caccamo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0215","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0168-8278(03)00470-7","article-title":"Epidemiological and clinical burden of chronic hepatitis B virus\/hepatitis C virus infection. A multicenter Italian study","volume":"39","author":"Gaeta","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0220","first-page":"221","article-title":"The spectrum of HBV\/HCV coinfection: epidemiology, clinical characteristics, viral interactions and management","volume":"28","author":"Konstantinou","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0225","first-page":"1","article-title":"Comparison of efficacy of entecavir and tenofovir in nucleos(t)ide analogue-experienced chronic hepatitis B patients","volume":"10","author":"Cho","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bjid.2017.03.019_bib0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/liv.12078","article-title":"Treatment of HBeAg positive chronic patients: interferon or nucleoside analogues","volume":"33","author":"Dusheiko","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.bjid.2017.03.019_bib0235","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.510290321","article-title":"Efficacy of lamivudine in patients with hepatitis B e antigen-negative\/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B","volume":"29","author":"Tassopoulos","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2017.03.019_bib0240","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1159\/000375357","article-title":"Antiviral therapy in hepatitis B virus associated liver cirrhosis","volume":"33","author":"Boettler","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.bjid.2017.03.019_bib0245","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1478-3231.2009.02198.x","article-title":"Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion","volume":"30","author":"Lau","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.bjid.2017.03.019_bib0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2017.03.019_bib0255","doi-asserted-by":"crossref","first-page":"13284","DOI":"10.3748\/wjg.v20.i37.13284","article-title":"Short- and long-term outcome of interferon therapy for chronic hepatitis B infection","volume":"20","author":"Seo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0260","first-page":"1","article-title":"Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis","volume":"13","author":"Kim","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bjid.2017.03.019_bib0265","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.26385","article-title":"Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles","volume":"58","author":"Lee","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2017.03.019_bib0270","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1440-1746.2011.06695.x","article-title":"Natural history of chronic hepatitis B revealed","volume":"26","author":"Chen","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","author":"Yang","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2017.03.019_bib0280","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bjid.2017.03.019_bib0285","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/apt.12344","article-title":"Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B","volume":"38","author":"Singal","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bjid.2017.03.019_bib0290","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jhep.2014.08.045","article-title":"Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir","volume":"63","author":"Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.bjid.2017.03.019_bib0295","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2008.03816.x","article-title":"Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma","volume":"28","author":"Sung","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bjid.2017.03.019_bib0300","series-title":"Associa\u00e7\u00e3o Brasileira de Transplantes de \u00d3rg\u00e3os (ABTO)","author":"Registro Brasileiro de Transplantes 2008\u20132015","year":"2015"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867016306286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867016306286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T07:03:37Z","timestamp":1535785417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867016306286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1413867016306286"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2017.03.019","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2017.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}